BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 15846301)

  • 1. Insulin-like growth factor binding protein-6 inhibits prostate cancer cell proliferation: implication for anticancer effect of diethylstilbestrol in hormone refractory prostate cancer.
    Koike H; Ito K; Takezawa Y; Oyama T; Yamanaka H; Suzuki K
    Br J Cancer; 2005 Apr; 92(8):1538-44. PubMed ID: 15846301
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The synthetic estrogen diethylstilbestrol (DES) inhibits the telomerase activity and gene expression of prostate cancer cells.
    Geier R; Adler S; Rashid G; Klein A
    Prostate; 2010 Sep; 70(12):1307-12. PubMed ID: 20623632
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Castration-induced increases in insulin-like growth factor-binding protein 2 promotes proliferation of androgen-independent human prostate LNCaP tumors.
    Kiyama S; Morrison K; Zellweger T; Akbari M; Cox M; Yu D; Miyake H; Gleave ME
    Cancer Res; 2003 Jul; 63(13):3575-84. PubMed ID: 12839944
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene profiling and promoter reporter assays: novel tools for comparing the biological effects of botanical extracts on human prostate cancer cells and understanding their mechanisms of action.
    Bigler D; Gulding KM; Dann R; Sheabar FZ; Conaway MR; Theodorescu D
    Oncogene; 2003 Feb; 22(8):1261-72. PubMed ID: 12606954
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The therapeutic and preventive effect of RRR-alpha-vitamin E succinate on prostate cancer via induction of insulin-like growth factor binding protein-3.
    Yin Y; Ni J; Chen M; DiMaggio MA; Guo Y; Yeh S
    Clin Cancer Res; 2007 Apr; 13(7):2271-80. PubMed ID: 17404112
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative effects of DHEA vs. testosterone, dihydrotestosterone, and estradiol on proliferation and gene expression in human LNCaP prostate cancer cells.
    Arnold JT; Le H; McFann KK; Blackman MR
    Am J Physiol Endocrinol Metab; 2005 Mar; 288(3):E573-84. PubMed ID: 15536203
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Castration-induced up-regulation of insulin-like growth factor binding protein-5 potentiates insulin-like growth factor-I activity and accelerates progression to androgen independence in prostate cancer models.
    Miyake H; Pollak M; Gleave ME
    Cancer Res; 2000 Jun; 60(11):3058-64. PubMed ID: 10850457
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential regulation of IGFBP-3 by the androgen receptor in the lineage-related androgen-dependent LNCaP and androgen-independent C4-2 prostate cancer models.
    Kojima S; Mulholland DJ; Ettinger S; Fazli L; Nelson CC; Gleave ME
    Prostate; 2006 Jun; 66(9):971-86. PubMed ID: 16541420
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Restoration of insulin-like growth factor binding protein-related protein 1 has a tumor-suppressive activity through induction of apoptosis in human prostate cancer.
    Mutaguchi K; Yasumoto H; Mita K; Matsubara A; Shiina H; Igawa M; Dahiya R; Usui T
    Cancer Res; 2003 Nov; 63(22):7717-23. PubMed ID: 14633696
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blockade of the type I IGF receptor expression in human prostate cancer cells inhibits proliferation and invasion, up-regulates IGF binding protein-3, and suppresses MMP-2 expression.
    Grzmil M; Hemmerlein B; Thelen P; Schweyer S; Burfeind P
    J Pathol; 2004 Jan; 202(1):50-9. PubMed ID: 14694521
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Castration-induced apoptosis of androgen-dependent shionogi carcinoma is associated with increased expression of genes encoding insulin-like growth factor-binding proteins.
    Nickerson T; Miyake H; Gleave ME; Pollak M
    Cancer Res; 1999 Jul; 59(14):3392-5. PubMed ID: 10416600
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Survivin mediates resistance to antiandrogen therapy in prostate cancer.
    Zhang M; Latham DE; Delaney MA; Chakravarti A
    Oncogene; 2005 Apr; 24(15):2474-82. PubMed ID: 15735703
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of 17beta-estradiol on apoptosis, IGF system components and gelatinases A and B in prostate cancer cells (PC-3).
    Kanagaraj P; Vijayababu MR; Ilangovan R; Senthilkumar K; Venkataraman P; Aruldhas MM; Arunakaran J
    Clin Chim Acta; 2007 Feb; 377(1-2):70-8. PubMed ID: 17083925
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of vitamin D-regulated gene expression in LNCaP human prostate cancer cells using cDNA microarrays.
    Krishnan AV; Shinghal R; Raghavachari N; Brooks JD; Peehl DM; Feldman D
    Prostate; 2004 May; 59(3):243-51. PubMed ID: 15042599
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of apoptosis by diethylstilbestrol in hormone-insensitive prostate cancer cells.
    Robertson CN; Roberson KM; Padilla GM; O'Brien ET; Cook JM; Kim CS; Fine RL
    J Natl Cancer Inst; 1996 Jul; 88(13):908-17. PubMed ID: 8656443
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GREB1 is a novel androgen-regulated gene required for prostate cancer growth.
    Rae JM; Johnson MD; Cordero KE; Scheys JO; Larios JM; Gottardis MM; Pienta KJ; Lippman ME
    Prostate; 2006 Jun; 66(8):886-94. PubMed ID: 16496412
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of zinc on regulation of insulin-like growth factor signaling in human androgen-independent prostate cancer cells.
    Banudevi S; Senthilkumar K; Sharmila G; Arunkumar R; Vijayababu MR; Arunakaran J
    Clin Chim Acta; 2010 Feb; 411(3-4):172-8. PubMed ID: 19913001
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Divergent biological effects of estradiol and diethylstilbestrol in the prostate cancer cell line MOP.
    Kalach JJ; Joly-Pharaboz MO; Chantepie J; Nicolas B; Descotes F; Mauduit C; Benahmed M; André J
    J Steroid Biochem Mol Biol; 2005 Jul; 96(2):119-29. PubMed ID: 15950459
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Growth inhibitory concentrations of androgens up-regulate insulin-like growth factor binding protein-3 expression via an androgen response element in LNCaP human prostate cancer cells.
    Peng L; Malloy PJ; Wang J; Feldman D
    Endocrinology; 2006 Oct; 147(10):4599-607. PubMed ID: 16825320
    [TBL] [Abstract][Full Text] [Related]  

  • 20. c-Jun enhancement of androgen receptor transactivation is associated with prostate cancer cell proliferation.
    Chen SY; Cai C; Fisher CJ; Zheng Z; Omwancha J; Hsieh CL; Shemshedini L
    Oncogene; 2006 Nov; 25(54):7212-23. PubMed ID: 16732317
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.